1207 - EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL).
Saved in:
| Title: | 1207 - EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). |
|---|---|
| Authors: | Ascierto, P., Bastholt, L., Mohr, P., Hoeller, C., Robert, C., Larkin, J., Dummer, R., Ekbom, A., Chiarion-Sileni, V., Dutriaux, C., Mortier, L., Neyns, B., Nyakas, M., Garbe, C., Baurain, J.F., Kruse, V., Svane, I.M., Alfaya, L., Ciria, C., Blank, C. |
| Source: | European Journal of Cancer. Feb2017 Supplement 1, Vol. 72, pS128-S128. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
